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Protein tyrosine phosphatase receptor type Z (Ptprz) is
widely expressed in the mammalian central ner-
vous system and has been suggested to regulate
oligodendrocyte survival and differentiation. We in-
vestigated the role of Ptprz in oligodendrocyte re-
myelination after acute, toxin-induced demyelina-
tion in Ptprz null mice. We found neither obvious
impairment in the recruitment of oligodendrocyte
precursor cells, astrocytes, or reactive microglia/mac-
rophage to lesions nor a failure for oligodendrocyte
precursor cells to differentiate and remyelinate axons
at the lesions. However, we observed an unexpected
increase in the number of dystrophic axons by 3 days
after demyelination, followed by prominent Walle-
rian degeneration by 21 days in the Ptprz-deficient
mice. Moreover, quantitative gait analysis revealed a
deficit of locomotor behavior in the mutant mice,
suggesting increased vulnerability to axonal injury.
We propose that Ptprz is necessary to maintain cen-
tral nervous system axonal integrity in a demyelinat-
ing environment and may be an important target of
axonal protection in inflammatory demyelinating dis-
eases, such as multiple sclerosis and periventricular
leukomalacia. (Am J Pathol 2012, 181:1518–1523; http://
dx.doi.org/10.1016/j.ajpath.2012.07.011)
Remyelination after myelin breakdown that occurs in de-
myelinating disease, such as multiple sclerosis, restores
1518function and protects axons, whereas its failure is asso-
ciated with the axonal loss that accounts for irreversible
deterioration in multiple sclerosis.1,2 Identifying pathways
critically involved in remyelination is fundamental to the
development of regenerative therapies that are currently
missing in the treatment of demyelinating diseases.3 Pro-
tein tyrosine phosphatases are a diverse group of en-
zymes that, together with protein tyrosine kinases, regu-
late tyrosine phosphorylation and hence coordinate
intracellular signaling responses. Protein receptor ty-
rosine phosphatase type Z (Ptprz; alias receptor-type
protein tyrosine phosphatase ) is widely expressed by
both neurons and glia in the developing and adult ner-
vous system and has been implicated in neuronal migra-
tion, morphogenesis, synapse formation, and paranode
formation.4–8
Ptprz is also expressed in oligodendrocyte lineage
cells and has been suggested to play a key role in oligo-
dendrocyte differentiation and myelination.9–11 However,
mice deficient in Ptprz do not display obvious behavioral
phenotype, and their CNS development, including myeli-
nation, appears grossly normal.12 By contrast, when sub-
ject to immune-mediated demyelination by experimental
autoimmune encephalomyelitis (EAE), Ptprz-deficient
mice exhibit sustained paralysis and poor functional re-
covery. In the spinal cords of these mice, widespread
apoptosis of oligodendrocytes has been observed, sug-
gesting that Ptprz may influence functional recovery from
demyelination by promoting oligodendrocyte survival.13
We analyzed CNS remyelination in Ptprz-deficient
mice using a simple toxin–based model of demyelination
to avoid the ambiguities of interpretation implicit in im-
mune-mediated models, such as EAE. We induced de-
myelination by injecting 1.0% lysolecithin into the spinal
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primary demyelination with relative preservation of ax-
ons.14 Unexpectedly, we observed extensive axonal loss
and Wallerian degeneration after lysolecithin injection in
the Ptprz null mice compared with wild-type (WT) mice.
This result, although shedding little light on the role of
Ptprz in remyelination, reveals an unexpected role of this
protein in protecting axons that have undergone primary
demyelination and therefore identifies it as a potential
and exciting novel target for neuroprotection in demyeli-
nating disease.
Materials and Methods
Animals
Ptprz-deficient mice (Ptprz/) were generated as de-
scribed previously.15 Briefly, the carbonic anhydrase and
fibronectin type III domains were replaced with the LacZ
reporter gene followed by 3 stop codons. WT littermates
(Ptprz/) were used as controls.
Surgery
All the surgical procedures were performed under a UK
Home Office Project license. Focal demyelination was
induced by injecting of 1.0% lysolecithin (Sigma-Aldrich
Company Ltd, Dorset, UK) in saline into the spinal cord
ventral funiculus of Ptprz null mice (Ptprz/) or WT litter-
mates (Ptprz/). CatWalk gait analysis was performed
as described previously.16 The animals were sacrificed
at 3, 5, 10, and 21 days after surgery for analysis.
Immunohistochemical Analysis
Mice (n  10 per group per survival time) were perfused
with 4.0% paraformaldehyde. Tissues were kept 3 hours
in the fixative, cryoprotected in 30% sucrose, and frozen
in isopentane. Sections (12 m thick) were cut in a cry-
ostat and kept at 80°C until use. For immunofluores-
cence, the sections were dried and washed in PBS with
0.3% of Triton. After blocking with normal donkey serum,
the sections were incubated with primary antibodies: rab-
bit anti-Olig2 (1:1000; Millipore, Billerica, MA) and rabbit
anti-NF200 (1:1000; Abcam, Cambridge, MA) overnight
at 4°C. For mouse anti-APC/CC1 (Ab-7) (1:300; Calbi-
ochem, San Diego, CA) and mouse anti-amyloid precur-
sor protein (APP) (clone 22C11) (1:400; Millipore) immu-
nostaining, antigen retrieval (Dako Real Target Retrieval
Solution; Dako, Glostrup, Denmark) and mouse on mouse
blocking (Vector Laboratories, Peterborough, UK) were
performed according to manufacturer instructions before
antibody incubation. For cell death analysis, TUNEL
staining was performed using the In Situ Cell Death De-
tection Kit, POD (Roche Diagnostics, Indianapolis, IN),
according to instruction before primary antibody incuba-
tion. After 2 washes in 1 PBS, the sections were incu-
bated with secondary antibody: Donkey (Dk) anti-mouse
Cy2, Dk anti-rabbit Cy3, Dk anti-rat Cy3 (all from Jackson
Immunoresearch Europe Ltd, Suffolk, UK), and Dk anti-rabbit Alexa 488 (Invitrogen, Paisley, UK). The sections
were observed in an Axio Observer microscope (Carl
Zeiss, Peabody, MA).
Electron Microscopy
Animals for resin embedding (n  10 per group) were
perfused with 2.0% glutaraldehyde (pH 7.4). The spinal
cords were dissected, and segments were left in the
same fixative overnight at 4°C. Tissues were postfixed in
2.0% of osmium tetroxide (Oxkem Limited, Reading, UK)
and embedded in resin (TAAB Labs, Aldermaston, UK).
Sections (1 m thick) were cut on a Leica (Milton Keynes,
UK) RM2065 ultramicrotome and stained with 1% toluid-
ine blue. Ultr-thin resin sections were observed at Hitachi
(Maidenhead, UK) H-600 electron microscope.
Quantitation and Analysis
Images were photographed with an Axio Observed mi-
croscope (Carl Zeiss). Images were taken at 20 or 40
magnification. Positive cells were counted and ex-
pressed per area. Six animals were used for each group,
and 3 sections of each animal were counted. The area
was calculated using Axiovision software version 4.7.1
(Carl Zeiss). Results are expressed as mean  SEM.
Statistical analysis was performed using one-way analy-
sis of variance followed by a post hoc Bonferroni’s multi-
ple comparison test and unpaired t-test. The data were
analyzed using Prism GraphPad program version 5.0b
(GraphPad Software Inc, San Diego, CA). P  0.05 was
considered statistically significant between samples.
Results
Ptprz Loss Does Not Influence OPC
Recruitment or Differentiation After
Spinal Cord Demyelination
To determine whether Ptprz plays a role in oligodendro-
cyte precursor cell (OPC) recruitment or differentiation,
focal demyelination was produced by lysolecithin injec-
tion into the left spinal cord ventral funiculus of Ptprz/
mice and Ptprz/ littermates (Figure 1A). Immunostain-
ing analysis was performed on spinal cord sections 10
and 21 days post lesion (dpl). We used Nkx2.2 as a
marker of recruited OPCs, CC1 as a marker of mature
oligodendrocytes, and Olig2 as a pan-oligodendrocyte
lineage marker.17 At 10 dpl, many OPCs co-labeled with
Nkx2.2 and Olig2 were observed in spinal cord lesions,
but we detected no significant difference in the number of
precursor cells between the two groups (Figure 1B). At
21 dpl, oligodendrocytes co-labeled with CC1 and Olig2
were observed in spinal cord lesions, but again we found
no significant difference in the density of mature oligo-
dendrocytes between the two groups (Figure 1C). These
results suggest that Ptprz was neither required for OPC
recruitment nor oligodendrocyte differentiation after de-
myelination.
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After Demyelination
We next performed morphologic analysis of transverse
semithin resin sections of spinal cords at 21 dpl, when
remyelination is expected to be near completion, to de-
termine whether there was a difference in the extent of
remyelination between Ptprz/ and Ptprz/ mice. Anal-
ysis of control littermates revealed a pattern and extent of
remyelination consistent with previously reported studies.
However, we found that Ptprz/ mice appeared to dis-
play relatively fewer remyelinated axons in the lesions.
When lesions were ranked blindly for the extent of remy-
elination, we found a significant difference between the
Figure 1. Oligodendrocyte progenitor cell recruitment and remyelination
are not impaired after lesion. A: Illustration of a transverse spinal cord
section with a focal lesion in the left ventral funiculus. B: A focal lesion
from a Ptprz/ mouse at 10 dpl immunostained with anti-Nkx2.2, anti-
Olig2, and DAPI. Ventral funiculus lesion can be observed within the
dashed line. Inset: Nkx2.2Olig2 and Nkx2.2Olig2 cells. Nkx2.2
and Olig2 are both detected in nuclei. Quantitation of Nkx2.2Olig2
OPCs at the lesion reveals no significant difference between Ptprz/
mice and control mice. C: A focal lesion from a Ptprz/ mouse at 21 dpl
immunostained with anti-CC1, anti-Olig2, and DAPI. Inset: CC1Olig2
and CC1Olig2 cells. CC1 displays cytoplasmic distribution. Quantita-
tion of CC1Olig2 oligodendrocytes reveals no significant difference
between the two groups. D: Ranking analysis on the extent of remyeli-
nation at 21 dpl reveals less remyelination in Ptprz/ mice compared
with WT siblings. E: Ranking analysis of the extent of demyelination at 21
dpl reveals no difference between the 2 groups. Scale bar  100 m.
Mean  SEM are shown. ***P  0.001, U-test.two groups (Figure 1D). This finding suggested that manyaxons might not have been remyelinated in the Ptprz/
mice, and if so, the mutant mice would be expected to
have more demyelinated axons in the lesions compared
with controls. However, when ranking analysis was per-
formed for histologically identifiable demyelinated axons
in the lesions, we found no significant difference between
the knockout and control groups (Figure 1E). A possible
explanation for the puzzling observation was that there
were fewer intact axons in the lesions of Ptprz/ mice at
21 dpl, and thus fewer axons were remyelinated, which
would account for the CC1 cell density remaining un-
changed despite less remyelination. Consistent with this
hypothesis, we also detected many dark-staining foci of
disrupted myelin, indicative of Wallerian degeneration in
the lesions of Ptprz/ mice, which is a feature rarely
detected in Ptprz/ controls (Figure 2A). This unex-
pected observation suggested that many CNS axons
might have degenerated by 21 dpl in the absence of
Ptprz expression.
A measurement of the extent of spinal cord lesions
between Ptprz/ and control animals revealed that the
longitudinal length of the lesions was at least several
hundred micrometers longer in mice lacking Ptprz com-
pared with control animals (Figure 2B). Moreover, the
transverse widths of the lesions were similar to each other
in the 2 groups (Figure 2C), consistent with the volume
and concentration of lysolecithin delivered to the ventral
spinal cord being the same in the 2 groups. These ob-
servations further indicate that by 21 dpl, many descend-
ing (ventrolateral) axons were undergoing distal degen-
eration in the Ptprz/mice.
To examine the extent of axon preservation in the le-
sion, we labeled axons with antibodies against neurofila-
ment (NF200) (Figure 2D). In nonlesioned white matter,
we found no significant difference in the number of
NF200 axons between Ptprz/ and control animals
(Figure 2E). However, the density of total NF200 axons
decreased by 25% at 10 dpl in the lesions of Ptprz/
mice compared with controls and decreased even further
by up to 75% at 21 dpl. This observation suggests that
many axons might have degenerated shortly after lyso-
lecithin injection. Indeed, electron microscopic examina-
tion of resin embedded sections revealed fewer intact
axons in the lesions of Ptprz/ mice compared with
controls (Figure 2F).
CNS Axons of Ptprz/ Mice Become
Dystrophic Shortly After Injury
To determine whether axonal abnormality in Ptprz/
mice could be detected in the lesions before degenera-
tion, we performed immunostaining analysis on trans-
verse spinal cord sections 3 dpl for the accumulated
expression of APPs as an indicator of potential distur-
bance in axonal transport.18,19 We found that APP dis-
played a strikingly punctate staining pattern in lesions
that rarely overlapped with TuJ1 in both analyzed
groups. However, we observed that mice lacking Ptprz
displayed more APP punctate staining in the lesions
when compared with controls (Figure 3A). Quantifica-
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more APP punctate stains in the lesions compared
with controls (Figure 3B). Moreover, swollen axons dis-
playing abnormal-appearing organelles were readily
detectable under light microscopy examination of resin
embedded sections at 3 dpl in Ptprz/ mice com-
pared with controls (Figure 3C). These results indicate
that in the absence of Ptprz, CNS axons became dys-
trophic after lysolecithin injection and were vulnerable
to degeneration. Next, to determine whether behavioral
deficit as result of acute axonal injury could be de-
tected, we subjected the Ptprz mouse mutants to Cat-
Walk gait analysis at 5 dpl (Figure 3D). CatWalk is an
automated system that uses video camera technology
to capture and analyze the intensity and duration of
paw contacts on a motion sensitive glass plate during
locomotion.16,20 We found that the lesioned Ptprz/
mice, when compared with lesioned WT siblings, dis-
played a significant decrease in contact intensity in
their left hind limb, corresponding to axonal injuries in
the left ventral funiculus where lysolecithin was in-
jected. Moreover, the lesioned Ptprz/ mice also dis-
played increased contact intensity and duration in their
right front paw when compared with controls, indica-
tive of behavioral compensation by the right front paw
to deficits in the left hind limb. The observed locomotor
behavioral deficits suggest that acute axonal injury in
the descending ventral lateral pathways was apparent
by 5 dpl. Moreover, this behavioral deficit was not
inherent to Ptprz loss of function in development be-
cause the nonlesioned Ptprz/ mice did not exhibit
locomotor abnormality and displayed similar paw con-
tact intensity and duration to the nonlesioned WT sib-
lings.
Analysis of Oligodendrocyte Apoptosis in
Ptprz/ Mouse Spinal Cord Lesions
Ptprz has previously been suggested to mediate func-
tional recovery from immune-mediated demyelination
after EAE induction via regulating oligodendrocyte sur-
Figure 2. Demyelination results in increased axon loss. A: A spinal cord
section from Ptprz/ and Ptprz / mice at 21 dpl. The control mouse
exhibits many remyelinated axons. Inset: A group of remyelinated axons.
Ptprz/ mouse displays dark, disorganized myelin whorls indicative of
Wallerian degeneration, which is rarely observed in control. Inset: An
axon undergoing Wallerian degeneration. Scale bar  20 m. B: Quan-
titation of lesion lengths at 21 dpl reveals significantly greater longitudinal
lesion in Ptprz/ mice compared with control. C: Quantitation of trans-
verse section of lesion at 21 dpl reveals no difference between Ptprz/
and control animals. **P  0.005, unpaired t-test. D: Spinal cord sections
of Ptprz/ and Ptprz/ mice at 21 dpl were immunostained with
anti-NF200 and DAPI. The lesion is detectable under the dashed line.
NF200 axons at the lesion are visibly less in the Ptprz/ mice. Scale
bar  50 m. E: Quantitation of NF200 axons in the non-lesioned white
matter (NWM) reveals no difference between Ptprz/ and control mice.
However, quantitation of axons in lesions reveals significantly fewer
axons in Ptprz/ mice compared with controls. F: Ultrastructure image
of a spinal cord section at 10 dpl from a Ptprz/ mouse reveals well-
preserved, intact demyelinated axons. The Ptprz/ mouse displays
fewer intact demyelinated axons within the lesion. Mean  SEM are
shown. *P  0.05, ***P  0.0001 one-way analysis of variance followed by
post hoc Bonferroni’s multiple comparison test.
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godendrocyte survival in focal lysolecithin-induced de-
myelination, we analyzed the extent of apoptosis in
spinal cord sections of Ptprz/ mice at 21 dpl. In situ
cell death detection by TUNEL staining followed by
immunolabeling with anti-Olig2 for oligodendrocyte lin-
eage cells were performed. We observed many TUNEL
Figure 4. Oligodendrocytes do not undergo significant apoptosis in the
anti-Olig2. Co-labeling of Olig2 and TUNEL staining was rarely detected in the lesio
of TUNELOlig2 cells in lesions (unpaired t-test).staining in the core of demyelinated lesions in WT
(Figure 4A) and Ptprz / mice (Figure 4B). However,
these apoptotic cells rarely co-labeled with Olig2 oli-
godendrocyte lineage cells in either the WT or Ptprz/
mice (Figure 4C), suggesting that Ptprz is not required
for oligodendrocyte survival after lysolecithin-induced
demyelination.
Figure 3. Axonal injury is detectable shortly after
lesion. A: Spinal cord sections at 3 dpl were im-
munostained with anti-APP and DAPI. Ptprz/
spinal cord sections displayed more punctate APP
staining in lesions compared with Ptprz/ sec-
tions. Scale bar 50 m. B:Quantification reveals
a significant increase in the number of APP punc-
tate stains in the lesions of Ptprz/ mice com-
pared with WT mice at 3 dpl. C: Semithin resin
sections stained with toluidine blue. Compared
with the control (Ptprz/) section, which displays
demyelinated axons (arrowheads), the Ptprz/
section displays abnormally swollen and dystro-
phic axons containing abnormal cytoskeletal den-
sities or organelles. Scale bar  5 m. D: CatWalk
gait analysis at 5 dpl reveals significantly decreased
paw intensity in the left hind limb of the lesioned
Ptprz/mice (knockout surgery) compared with
controls. Increased right front paw intensity and
stand phase (duration) were also detected in the
lesioned Ptprz/ mice. Mean  SEM are shown.
*P  0.05, **P  0.01 unpaired t-test.
n situ cell death assay was performed followed by immunostaining with
/lesion. I
ns of WT (A) and Ptprz (B) mice. Scale bar  50 m. C: Quantification
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In this study, we found that Ptprz does not play a
significant role in oligodendrocyte survival, differentia-
tion, or remyelination after acute lysolecithin-induced
demyelination but that its expression appears to be
required for axonal integrity and survival. We found that
the loss of axons correlated with the acute deficit of
motor behavior in the lesioned Ptprz/ mice. The ax-
onal degeneration observed in the Ptprz/ mice re-
sembles Wallerian degeneration when compared with
the Ptprz/ mice, which exhibited a picture consistent
with primary demyelination. Therefore, the lack of Ptprz
makes axons more vulnerable when a demyelinating
agent is injected into the spinal cord white matter tract.
Induction of Ptprz mRNA in areas of axonal sprouting
and glial scarring after CNS injury, implying that cell
adhesion molecules and the extracellular matrix pro-
teins to which these receptors bind to may be involved
in axonal injury responses21,22 and linking Ptprz with
axonal protection.
It remains unclear why under immune-mediated demy-
elination an increase in oligodendrocyte apoptosis would
occur as described previously,13 but this increase may
indicate a fundamental difference in how CNS cells re-
spond under different injury conditions. However, the in-
herent ambiguity of EAE, such as i) the difficulty to predict
and track the locations of demyelination; ii) the variability
in the degree of inflammation, which can result either in
demyelination or axonal transections; and iii) the added
complexity of the adaptive immune system, may limit the
analysis of regenerative or survival mechanisms intrinsic
to OPCs. A possible explanation for the increased oligo-
dendrocyte apoptosis found in EAE-induced Ptprz/
mice may be that oligodendrocytes undergo death as
result of a secondary injury process to Wallerian degen-
eration and that the loss of axons contributed to the
impaired functional recovery from EAE.23,24 In support of
this possibility, prominent Wallerian degeneration was
indeed observed in EAE-induced Ptprz/ mice.13 In
conclusion, we propose Ptprz is critically involved in the
maintenance of axonal integrity. Thus, Ptprz could repre-
sent a key gene in maintaining axonal integrity after CNS
injury.
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